Abstract
By array-CGH, we identified a cryptic deletion of about 3.4 Mb involving the chromosomal region 11q13.2q13.4 in a child with speech and developmental delay. Highly homologous segmental duplications related to the well-known olfactory receptor (OR)-containing clusters at 8p and 4p are located at the breakpoints of the imbalance and may be involved in its occurrence. Although these structural features are known to promote recurrent chromosomal rearrangements and previous studies had included the 11q13.2q13.4 deletion region among those considered potentially more unstable, neither deletions nor duplications of this region had been reported until now. Among the deleted genes, SHANK2 might play a role in the phenotype of the patient since it encodes a postsynaptic scaffolding protein similar to SHANK3, whose haploinsufficiency is a well-known cause of severe speech delay and autistic-like behavior, and recently deletions and mutations of SHANK2 have been described in patients with an autistic spectrum disorder or mental retardation.
References
1.
Ackley BD, Harrington RJ, Hudson ML, Williams L, Kenyon CJ, et al: The two isoforms of the Caenorhabditis elegans leukocyte-common antigen related receptor tyrosine phosphatase PTP-3 function independently in axon guidance and synapse formation. J Neurosci 25:7517–7528 (2005).
2.
Antonacci F, Kidd JM, Marques-Bonet T, Ventura M, Siswara P, et al: Characterization of six human disease-associated inversion polymorphisms. Hum Mol Genet 18:2555–2566 (2009).
3.
Berkel S, Marshall CR, Weiss B, Howe J, Roeth R, et al: Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 42:489–491 (2010).
4.
Bonaglia MC, Giorda R, Mani E, Aceti G, Anderlid BM, et al: Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. J Med Genet 43:822–828 (2006).
5.
Bourgeron T: A synaptic trek to autism. Curr Opin Neurobiol 19:231–234 (2009).
6.
Bray N, Pachter L: MAVID: constrained ancestral alignment of multiple sequences. Genome Res 14:693–699 (2004).
7.
Bush JO, Lan Y, Jiang R: The cleft lip and palate defects in Dancer mutant mice result from gain of function of the Tbx10 gene. Proc Natl Acad Sci USA 101:7022–7027 (2004).
8.
Coldren CD, Lai Z, Shragg P, Rossi E, Glidewell SC, et al: Chromosomal microarray mapping suggests a role for BSX and neurogranin in neurocognitive and behavioral defects in the 11q terminal deletion disorder (Jacobsen syndrome). Neurogenetics 10:89–95 (2009).
9.
Falley K, Schütt J, Iglauer P, Menke K, Maas C, et al: Shank1 mRNA: dendritic transport by kinesin and translational control by the 5′ untranslated region. Traffic 10:844–857 (2009).
10.
Gauthier J, Spiegelman D, Piton A, Lafrenière RG, Laurent S, et al: Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet 150B:421–424 (2009).
11.
Giglio S, Broman KW, Matsumoto N, Calvari V, Gimelli G, et al: Olfactory receptor-gene clusters, genomic-inversion polymorphisms, and common chromosome rearrangements. Am J Hum Genet 68:874–883 (2001).
12.
Giglio S, Calvari V, Gregato G, Gimelli G, Camanini S, et al: Heterozygous submicroscopic inversions involving olfactory receptor-gene clusters mediate the recurrent t(4;8)(p16;p23) translocation. Am J Hum Genet 71:276–285 (2002).
13.
Grabrucker A, Vaida B, Bockmann J, Boeckers TM: Synaptogenesis of hippocampal neurons in primary cell culture. Cell Tissue Res 338:333–341 (2009).
14.
Gregory-Evans CY, Moosajee M, Hodges MD, Mackay DS, Game L, et al: SNP genome scanning localizes oto-dental syndrome to chromosome 11q13 and microdeletions at this locus implicate FGF3 in dental and inner-ear disease and FADD in ocular coloboma. Hum Mol Genet 16:2482–2493 (2007).
15.
Hastings PJ, Lupski JR, Rosenberg SM, Ira G: Mechanisms of change in gene copy number. Nat Rev Genet 10:551–564 (2009).
16.
Kim SM, Choi KY, Cho IH, Rhy JH, Kim SH, et al: Regulation of dendritic spine morphology by SPIN90, a novel Shank binding partner. J Neurochem 109:1106–1117 (2009).
17.
Lee JA, Carvalho CM, Lupski JR: A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 131:1235–1247 (2007).
18.
López FJ, Merchenthaler I, Ching M, Wisniewski MG, Negro-Vilar A: Galanin: a hypothalamic-hypophysiotropic hormone modulating reproductive functions. Proc Natl Acad Sci USA 88:4508–4512 (1991).
19.
Lupski JR: Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet 14:417–422 (1998).
20.
Mattina T, Perrotta CS, Grossfeld P: Jacobsen syndrome. Orphanet J Rare Dis 4:9 (2009).
21.
Muraille E, Dassesse D, Vanderwinden JM, Cremer H, Rogister B, et al: The SH2 domain-containing 5-phosphatase SHIP2 is expressed in the germinal layers of embryo and adult mouse brain: increased expression in N-CAM-deficient mice. Neuroscience 105:1019–1030 (2001).
22.
Nishimura T, Utsunomiya Y, Hoshikawa M, Ohuchi H, Itoh N: Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain. Biochim Biophys Acta 1444:148–151 (1999).
23.
Pramparo T, Gregato G, De Gregori M, Friso A, Clementi M, et al: Reciprocal translocation associated with multiple exostoses in seven members of a three generation family and discovered through an infertile male. Am J Med Genet A 123:79–83 (2003).
24.
Prasad NK, Decker SJ: SH2-containing 5′-inositol phosphatase, SHIP2, regulates cytoskeleton organization and ligand-dependent down-regulation of the epidermal growth factor receptor. J Biol Chem 280:13129–13136 (2005).
25.
Roth DB, Porter TN, Wilson JH: Mechanisms of nonhomologous recombination in mammalian cells. Mol Cell Biol 5:2599–2607 (1985).
26.
Roussignol G, Ango F, Romorini S, Tu JC, Sala C, et al: Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J Neurosci 25:3560–3570 (2005).
27.
Schwartz S, Zhang Z, Frazer KA, Smit A, Riemer C, et al: PipMaker–a web server for aligning two genomic DNA sequences. Genome Res 10:577–586 (2000).
28.
Sharp AJ, Hansen S, Selzer RR, Cheng Z, Regan R, et al: Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat Genet 38:1038–1042 (2006).
29.
Sugawara H, Harada N, Ida T, Ishida T, Ledbetter DH, et al: Complex low-copy repeats associated with a common polymorphic inversion at human chromosome 8p23. Genomics 82:238–244 (2003).
30.
Yang T, Yin W, Derevyanny VD, Moore LA, Longo FM: Identification of an ectodomain within the LAR protein tyrosine phosphatase receptor that binds homophilically and activates signalling pathways promoting neurite outgrowth. Eur J Neurosci 22:2159–2170 (2005).
31.
Zhang F, Gu W, Hurles ME, Lupski JR: Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet 10:451–481 (2009).
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
